US gives go ahead to Alzheimer's drug

The US food and drug administration has cleared Eisai's Alzheimer's drug, Aricept, to treat severe dementia in patients with the degenerative brain disease.

    Ronald Reagan suffered from Alzheimer's

    The drug, which is also marketed by Pfizer, is already approved to treat mild to moderate dementia in patients of Alzheimer's, which affects roughly 4.5 million mostly older Americans.

    There is no cure for the condition, typified by memory loss and other cognitive impairment that can quickly worsen.

    Alzheimer's is the most common form of dementia.

    Eisai, based in Japan, earlier this month cited growing US sales of the drug thanks to Medicare's new prescription drug benefit for the elderly and disabled.

    It has forecast total Aricept sales at $1.9 billion, for the fiscal year through March 2007. Some analysts have said that estimate is conservative, but company officials have declined to comment.

    SOURCE: Reuters


    YOU MIGHT ALSO LIKE

    Women under ISIL: The wives

    Women under ISIL: The wives

    Women married to ISIL fighters share accounts of being made to watch executions and strap explosives to other women.

    Diplomats for sale: How an ambassadorship was bought and lost

    Diplomats for sale: How an ambassadorship was bought and lost

    The story of Ali Reza Monfared, the Iranian who tried to buy diplomatic immunity after embezzling millions of dollars.

    Crisis of Aboriginal women in prison in Australia

    Crisis of Aboriginal women in prison in Australia

    Aboriginal women are the largest cohort of prisoners in Australia, despite making up only 2 percent of the population.